Literature DB >> 25664108

Acute chest syndrome in severity of sickle cell diseases.

Mehmet Rami Helvaci1, Can Acipayam2, Akin Aydogan1, Seckin Akkucuk1, Cem Oruc1, Cumali Gokce1.   

Abstract

BACKGROUND: Sickle cell diseases (SCDs) are chronic inflammatory processes on capillary level. We tried to understand whether or not there are some positive correlations between acute chest syndrome (ACS) and severity of SCDs.
METHODS: All patients with the SCDs were taken into the study.
RESULTS: The study included 337 cases (167 females). There were 15 patients (4.4%) with the ACS. The mean ages were similar in both groups (29.4 versus 29.7 years in the ACS group and other, respectively, P > 0.05). The female ratios were similar in both groups, too (60.0% versus 49.0%, respectively, P > 0.05). Additionally, prevalences of associated thalassemia minors were similar in them (66.6% versus 65.5%, respectively, P > 0.05). Smoking was higher in the ACS group (20.0% versus 13.9%), but the difference was nonsignificant (P > 0.05). Although the mean white blood cell count and hematocrit value of peripheric blood were higher in the ACS group, the mean platelet count was lower in them, but the differences were nonsignificant again (P > 0.05 for all). On the other hand, although the painful crises per year, tonsilectomy, priapism, ileus, digital clubbing, pulmonary hypertension, rheumatic heart disease, cirrhosis, stroke, and mortality were higher in the ACS group, the difference was only significant for the stroke (P < 0.05), probably due to the small sample size of the ACS group.
CONCLUSION: SCDs are chronic destructive processes on capillaries iniatiating at birth, and terminate with early organ failures in life. Probably ACS is one of the terminal consequences of the inflammatory processes that may indicate shortened survival in such patients.

Entities:  

Keywords:  Acute chest syndrome; atherosclerosis; chronic capillary damage; sickle cell diseases

Year:  2014        PMID: 25664108      PMCID: PMC4307555     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  28 in total

1.  Prediction of adverse outcomes in children with sickle cell disease.

Authors:  S T Miller; L A Sleeper; C H Pegelow; L E Enos; W C Wang; S J Weiner; D L Wethers; J Smith; T R Kinney
Journal:  N Engl J Med       Date:  2000-01-13       Impact factor: 91.245

Review 2.  Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.

Authors:  S Charache
Journal:  Semin Hematol       Date:  1997-07       Impact factor: 3.851

3.  Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.

Authors:  Micah R Fisher; Paul R Forfia; Elzbieta Chamera; Traci Housten-Harris; Hunter C Champion; Reda E Girgis; Mary C Corretti; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2009-01-22       Impact factor: 21.405

4.  Sickle cell diseases and ileus.

Authors:  Mehmet Rami Helvaci; Akin Aydogan; Seckin Akkucuk; Cem Oruc; Mustafa Ugur
Journal:  Int J Clin Exp Med       Date:  2014-09-15

5.  Sickle cell vaso-occlusion in an animal model; intravital microscopy and radionuclide imaging of selective sequestration of dense cells.

Authors:  J Kurantsin-Mills; H M Jacobs; L S Lessin
Journal:  Prog Clin Biol Res       Date:  1987

Review 6.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

7.  Is pain crisis a cause of death in sickle cell disease?

Authors:  N A Parfrey; W Moore; G M Hutchins
Journal:  Am J Clin Pathol       Date:  1985-08       Impact factor: 2.493

8.  "Acute chest syndrome" in adults with sickle cell anemia. Microbiology, treatment, and prevention.

Authors:  S Charache; J C Scott; P Charache
Journal:  Arch Intern Med       Date:  1979-01

Review 9.  Pathophysiology and treatment of stroke in sickle-cell disease: present and future.

Authors:  Jeffrey A Switzer; David C Hess; Fenwick T Nichols; Robert J Adams
Journal:  Lancet Neurol       Date:  2006-06       Impact factor: 44.182

10.  Metformin and parameters of physical health.

Authors:  Mehmet Rami Helvaci; Hasan Kaya; Ali Borazan; Cahit Ozer; Mahmut Seyhanli; Atilla Yalcin
Journal:  Intern Med       Date:  2008-04-16       Impact factor: 1.271

View more
  2 in total

Review 1.  Secondhand Smoke Is an Important Modifiable Risk Factor in Sickle Cell Disease: A Review of the Current Literature and Areas for Future Research.

Authors:  S Christy Sadreameli; Benjamin T Kopp; Susan E Creary; Michelle N Eakin; Sharon McGrath-Morrow; John J Strouse
Journal:  Int J Environ Res Public Health       Date:  2016-11-12       Impact factor: 3.390

2.  Evaluation of Alpha-1 Antitrypsin Levels and SERPINA1 Gene Polymorphisms in Sickle Cell Disease.

Authors:  Magda Oliveira Seixas Carvalho; André Luís Carvalho Santos Souza; Mauricio Batista Carvalho; Ana Paula Almeida Souza Pacheco; Larissa Carneiro Rocha; Valma Maria Lopes do Nascimento; Camylla Vilas Boas Figueiredo; Caroline Conceição Guarda; Rayra Pereira Santiago; Adekunle Adekile; Marilda de Souza Goncalves
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.